Binita Chakraborty

Research Scientist

Pharmacology & Cancer Biology

binita.das@duke.edu

More About This Person

At a Glance

Credentials

Academic Experience
1. Current Appointments & Affiliations

Expertise

Research
1. Selected Grants

Publications
1. Selected Publications

Artistic Works / Events

Teaching

Advising & Mentoring

Recognition

Professional Activities

Embed Profile Data

Embed Profile Data

Selected Grants

Manipulating normal estrogen physiology as a therapeutic approach in cancer

ResearchResearch Scientist · Awarded by National Cancer Institute · 2023 - 2028

Development of Novel ERRalpha Antagonists as Breast Cancer Therapeutics

ResearchResearch Scientist · Awarded by National Institutes of Health · 2022 - 2024

Evaluation of the efficacy of a combined regimen including an ER targeted therapy and ICB

ResearchResearch Scientist · Awarded by Sermonix Pharmaceuticals · 2023 - 2024

Cancer cell intrinsic and extrinsic actions of steroid hormones in breast tumors

ResearchPostdoctoral Associate · Awarded by Department of Defense · 2018 - 2023

Evaluation of estrogen receptor as a therapeutic target in melanoma, lung and colorectal cancer models

ResearchPostdoctoral Associate · Awarded by Zentalis Pharmaceuticals · 2020 - 2022

Pharmacological targeting of estrogen receptor to enhance melanoma immunity

ResearchPostdoctoral Associate · Awarded by The Melanoma Research Foundation · 2019 - 2021

Evaluation of novel CDK4/6/9 inhibitors in triple negative breast cancer

ResearchPostdoctoral Associate · Awarded by SPV Therapeutics, Inc · 2020 - 2020